Preview Mode Links will not work in preview mode

Sep 11, 2021

Featuring perspectives from Dr Zofia Piotrowska and Ms Tara Plues, including the following topics:

  • Introduction (0:00)
  • A woman in her early 50s with non-small cell lung cancer (NSCLC) with an EGFR exon 19 mutation (1:44)
  • A man in his mid-60s with newly diagnosed metastatic adenocarcinoma of the lung — PD-L1 95%...


Sep 8, 2021

Featuring slide presentations and related discussion from Drs Mark Awad, David R Spigel and Heather Wakelee, including the following topics:

  • Current and Potential Role of Immune Checkpoint Inhibition in the Management of Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) — Heather Wakelee, MD (0:00)
  • First-Line...


Sep 8, 2021

Featuring perspectives from Drs Mark Awad, David R Spigel and Heather Wakelee, including the following topis:

  • Immunotherapy in the (Neo)Adjuvant Setting
    • Introduction (0:00)
    • Case: A woman in her mid-60s with adenocarcinoma of the lung — PD-L1 of 0 — Sulfi Ibrahim, MD (1:39)
    • Key relevant data sets...


Sep 1, 2021

Featuring slide presentations and related discussion from Prof Solange Peters and Drs Zofia Piotrowska and Gregory J Riely, including the following topics:

  • Shaping the Current and Future Treatment of NSCLC with ALK and ROS1 Rearrangements — Professor Solange Peters, MD, PhD (0:00)
  • Key Data Guiding the Management of...


Sep 1, 2021

Featuring perspectives from Prof Solange Peters and Drs Zofia Piotrowska and Gregory J Riely, including the following topics:

  • Current and Future Treatment of Non-Small Cell Lung Cancer (NSCLC) with Targetable Mutations, Including ALK and ROS1
    • Introduction: Targeted treatment in the adjuvant setting (0:00)
    • Case: A man...